Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Consolidated Statements of Operations
Revenues	$ 3,331,898	$ 3,827,108	$ 10,371,235	$ 11,071,991
Cost of expenses:
Cost of revenues	1,489,703	1,647,033	4,713,839	4,779,657
Research and development expenses	186,352	231,742	600,205	641,255
Selling, general, and administrative expenses	2,107,303	1,585,989	5,814,285	4,946,624
Total costs and expenses	3,783,358	3,464,764	11,128,329	10,367,536
(Loss)/Income from operations	(451,460)	362,344	(757,094)	704,455
Interest expense - related party	41,400	44,367	122,850	141,933
Other Loss			5,221
(Loss)/Income before income taxes	(492,860)	317,977	(885,165)	562,522
(Benefit) provision for income taxes	86,500	136,677	(11,141)	234,512
Net (loss)/income	$ (579,360)	$ 181,300	$ (874,024)	$ 328,010
Net (loss)/income per common share - basic	$ (0.08)	$ 0.02	$ (0.11)	$ 0.04
Net (loss)/income per common share - diluted	$ (0.08)	$ 0.02	$ (0.11)	$ 0.04
Weighted average number of common shares outstanding - basic	7,696,091	7,690,199	7,693,069	7,676,170
Weighted average number of common shares outstanding - diluted	7,696,091	7,751,483	7,693,069	7,725,333